Cargando…
Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
AIMS: The incidence of cardiovascular events (CVEs) in patients with rheumatoid arthritis (RA) is higher than that in people without RA. This may be because inflammation promotes the progression of atherosclerosis. Anti-inflammatory drugs might reduce the occurrence of CVEs in patients with RA. Meth...
Autores principales: | Sun, Kai-jun, Liu, Lei-ling, Hu, Jia-hui, Chen, Yan-ying, Xu, Dan-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899830/ https://www.ncbi.nlm.nih.gov/pubmed/33607787 http://dx.doi.org/10.1097/MD.0000000000024579 |
Ejemplares similares
-
Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021) -
Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report
por: Miyata, Masayuki, et al.
Publicado: (2023) -
Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Lyu, Qian, et al.
Publicado: (2023) -
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
por: Migita, Kiyoshi, et al.
Publicado: (2015) -
The optimal dosage of pefcitinib for the treatment of active rheumatoid arthritis: A protocol for an updated network meta-analysis
por: Zhou, Yuyi, et al.
Publicado: (2021)